Inmune Bio Income Statement (2017-2025) | INMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.00M		0.01M	0.16M	0.16M	0.02M	0.10M	0.10M	0.04M	0.05M	0.04M	0.03M	0.01M				0.05M
Operating items
Research & Development (Quarter)	2.49M	4.46M	6.52M	7.07M	4.31M	4.19M	5.16M	3.41M	4.13M	4.15M	5.99M	6.01M	8.69M	7.05M	10.07M	7.35M	7.64M	5.80M	4.89M	2.33M
Selling, General & Administrative (Quarter)	2.06M	2.09M	2.52M	2.12M	2.33M	2.21M	2.38M	2.33M	2.33M	2.31M	2.59M	2.40M	2.34M	2.81M	2.22M	2.11M	2.32M	2.25M	2.55M	3.15M
Other Operating Expenses (Quarter)	-0.01M				-0.42M				-0.11M	-0.09M			-0.01M	0.12M				16.51M
Operating Expenses (Quarter)	4.55M	6.55M	9.04M	9.19M	6.64M	6.40M	7.54M	5.74M	6.46M	6.46M	8.57M	8.41M	11.03M	9.87M	12.29M	9.47M	9.96M	24.57M	7.43M	5.47M
Operating Income (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
EBIT (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	-0.01M												-0.01M				0.17M
Non Operating Income (Quarter)	-0.01M	0.10M	0.44M	0.64M	0.42M	0.45M	0.28M	-2.50M	0.11M	0.09M	-0.04M	-0.03M	-0.01M	0.12M	0.19M	0.25M	0.17M	0.11M	0.96M	0.21M
Net income details
EBT (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Profit After Tax (Quarter)	-4.56M	-6.66M	-9.46M	-9.67M	-6.90M	-6.84M	-7.72M	-5.83M	-6.54M	-6.50M	-8.56M	-8.40M	-11.03M	-9.75M	-12.09M	-9.22M	-9.74M	-24.46M	-6.47M	-5.23M
Income from Continuing Operations (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Consolidated Net Income (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Income towards Parent Company (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Net Income towards Common Stockholders (Quarter)	-4.55M	-6.55M	-9.02M	-9.03M	-6.48M	-6.39M	-7.44M	-5.64M	-6.42M	-6.41M	-8.53M	-8.38M	-11.02M	-9.87M	-12.29M	-9.47M	-9.90M	-24.57M	-7.43M	-5.47M
Additional items
EPS (Basic) (Quarter)	-0.32	-0.44	-0.55	-0.55	-0.39	-0.38	-0.43	-0.32	-0.36	-0.36	-0.48	-0.47	-0.61	-0.50	-0.60	-0.40	-0.43	-1.05	-0.24	-0.18
EPS (Weighted Average and Diluted) (Quarter)			-0.58	-0.56	-0.36	-0.36	-0.42	-0.31	-0.36	-0.36	-0.48	-0.47	-0.61	-0.50	-0.60	-0.40	-0.43	-1.05	-0.24	-0.18
Shares Outstanding (Weighted Average) (Quarter)	0.03M	0.03M	0.03M	16.13M	17.87M	17.91M	17.95M	17.93M	17.95M	0.05M	0.03M	0.05M	18.03M	18.67M	0.05M	2.34M	22.50M	23.30M	24.14M	1.56M
Shares Outstanding (Diluted Average) (Quarter)			15.55M	16.13M	17.87M	17.95M	17.92M	17.93M	17.95M	17.95M	17.97M	17.98M	18.03M	19.31M	20.19M	19.94M	22.50M	22.90M	24.14M	24.76M
EBITDA (Quarter)	-4.55M	-6.72M	-9.53M	-9.55M	-6.85M	-7.59M	-8.17M	-5.39M	-6.54M	-6.50M	-8.59M	-8.47M	-10.89M	-9.79M	-12.42M	-8.76M	-9.77M	-24.61M	-6.47M	-5.24M

Research Tools

Inmune Bio Income Statement (2017-2025) | INMB

Create an account

Sign In

Reset Password